BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 19429983)

  • 1. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
    Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
    Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and significance of PTEN in canine mammary gland tumours.
    Qiu C; Lin D; Wang J; Wang L
    Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex carcinomas of the mammary gland in cats: pathological and immunohistochemical features.
    Seixas F; Pires MA; Lopes CA
    Vet J; 2008 May; 176(2):210-5. PubMed ID: 17459738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops.
    Millanta F; Silvestri G; Vaselli C; Citi S; Pisani G; Lorenzi D; Poli A
    Res Vet Sci; 2006 Dec; 81(3):350-7. PubMed ID: 16556453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
    Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
    Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential.
    Millanta F; Calandrella M; Citi S; Della Santa D; Poli A
    Vet Pathol; 2005 Jan; 42(1):30-4. PubMed ID: 15657269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
    de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
    Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the PTEN tumor suppressor gene in malignant mammary gland tumors of dogs.
    Kanae Y; Endoh D; Yokota H; Taniyama H; Hayashi M
    Am J Vet Res; 2006 Jan; 67(1):127-33. PubMed ID: 16426222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of p27 expression in canine mammary tumors and their metastases.
    Klopfleisch R; Schütze M; Gruber AD
    Res Vet Sci; 2010 Apr; 88(2):300-3. PubMed ID: 19748645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
    Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
    Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metallothionein expression in canine and feline mammary and melanotic tumours.
    Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
    J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular phenotype of primary mammary tumours and distant metastases in female dogs and cats.
    Beha G; Muscatello LV; Brunetti B; Asproni P; Millanta F; Poli A; Benazzi C; Sarli G
    J Comp Pathol; 2014; 150(2-3):194-7. PubMed ID: 24060151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours.
    Jakab C; Halász J; Szász AM; Kiss A; Schaff Z; Rusvai M; Gálfi P; Kulka J
    J Comp Pathol; 2008 Nov; 139(4):238-45. PubMed ID: 18848337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas.
    Millanta F; Lazzeri G; Vannozzi I; Viacava P; Poli A
    Vet Pathol; 2002 Nov; 39(6):690-6. PubMed ID: 12450199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of CD44 adhesion factor in canine mammary carcinomas.
    Madrazo J; García-Fernández RA; García-Iglesias MJ; Durán AJ; Espinosa J; Pérez-Martínez C
    Vet J; 2009 Jun; 180(3):371-6. PubMed ID: 18299241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-rich carcinomas of the mammary gland in seven dogs: clinicopathologic and immunohistochemical features.
    Espinosa de los Monteros A; Hellmén E; Ramírez GA; Herráez P; Rodríguez F; Ordás J; Millán Y; Lara A; Martín de las Mulas J
    Vet Pathol; 2003 Nov; 40(6):718-23. PubMed ID: 14608030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of protein p53 in neoplasms of the mammary gland in bitches.
    Rodo A; Malicka E
    Pol J Vet Sci; 2008; 11(2):89-95. PubMed ID: 18683536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression levels of the focal adhesion-associated proteins paxillin and p130CAS in canine and feline mammary tumors.
    Scibelli A; d'Angelo D; Pelagalli A; Tafuri S; Avallone L; Della Morte R; Staiano N
    Vet Res; 2003; 34(2):193-202. PubMed ID: 12657211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers.
    Millanta F; Citi S; Della Santa D; Porciani M; Poli A
    Breast Cancer Res Treat; 2006 Jul; 98(1):115-20. PubMed ID: 16538539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.